cancer AI
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.
The AI, integrated into a hand-held point-of-care device, demonstrated 94% diagnostic accuracy.
Lunit and Coreline Soft have been tapped to join large-scale cancer screening programs.
Claimed to be a world's first, the LLM-driven model has demonstrated over 90% accuracy.